Senologická sekce ČGPS



Sekce perinatální medicíny
ČGPS

Literatura k odborné části

  1. Alexander, F.E., Anderson, T.J., Brown, H.K., Forrest, A.P., Hepburn, W., Kirkpatrick, A.E.: The Edinburgh randomized trial of breast cancer screening: results after 10 years of follow-up. Br. J. Cancer, 70, 1994, s. 542-548.
  2. Anderson, D.E.: Familial versus sporadic breast cancer. Cancer. 70, 1992, s. 1740-46.
  3. Andersson, I., Aspegren, K., Janzon, L., Landberg, T., Lindholm, K., Linell, F.: Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial, Br. Med. J., 297, 1988. s 943-948.
  4. Andersson, I., Janzon, L.: Reduced breast cancer mortality in women under age 50: updated results from Malmo mammographic screening program, J. Natl. Cancer Inst. Monogr., 22, 1997, 63-69.
  5. Athma, P., Rappaport, R., Swift M.: Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet. Cytogenet., 92, 1992, s.130-134.
  6. Auvinen, A., Elovainio, L., Hakama, M.: Breast self-examination and survival from breast cancer. A prospective examination and survival from breast cancer. A prospective follow-up study. Breast Cancer Res. Treat., 38, 1996, s. 161-68.
  7. Bjurstam, N., Bjomeld, L. Duffy, S.W., Smith, T.C., Cahlin, E., Eriksson, O.: The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization, Cancer, 80, 1997, s. 2091-2099.
  8. Boardman, L.A., Thibodeau, S.N., Schaid, D.L.: Increased risk for cancer in patients with the Peutz-Jeghers syndrome, Ann. Intern. Med., 128, 1998, s. 896-899.
  9. Claus E.B., Thompson W.D., Risch, N.: The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res.Treat., 28, 1993, s. 115-120.
  10. Cornelis, R.S., Van-Vliet, M., Van deVijver, M.J., Vasen, H.F.A., Voute, P.A., Top, B., Khan, P.M., Devillee, P., Cornelisse, C.J.: Three germline mutations in the TP 53 gene. Hum. Mutat., 9, 1997, 2, s. 157-63.
  11. Easton D.F., Ford D., Bishop D.T.: Breast cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am. J. Hum.Genet., 56, 1995, s. 265 - 71.
  12. Ford D., Easton D.F., Bishop D.T.: Risks of cancer in BRCA1-mutation carriers. Lancet, 343, 1994, s. 692 - 695.
  13. Frisell, J., Eklund, G., Hellstrom, L., Lidbrink, E., Rutqvist, L.E., Somell, A.: Randomized study of mammography screening – preliminary report on mortality in the Stockholm trial, Breast Cancer Res.Treat., 18, 1991, s. 49-55.
  14. Gail, M.H., Brinton, L.A., Byar, D.P.: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually, J. Natl. Cancer Inst., 81, 1989, s. 1879-1883.
  15. Gotzsche, P.C., Olsen, O..: Is screening for breast cancer with mammography justifiable ? Lancet, 355, 2000, s. 129-134.
  16. Gotzsche, P.C., Olsen, O..: Screening mammography re-evaluated, Lancet, 355, 2000, s. 752-753.
  17. Hall, N.R., Williams, M.A., Murday, V.A., Newton, J.A., Bishop, D.T: Muir-Torre syndrome: a variant of the cancer family syndrome. J. Med. Genet., 31, 1994, s. 627-631.
  18. Hendrick, R.E., Smith, R.A., Rutledge, J,H.3rd, Smart, C.R.: Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials, J. Natl. Cancer Inst. Monogr., 22, 1997, s. 87-92.
  19. Holmberg, L., Ekbom, A., Calle, E., Kokdad, A., Byers, T.: Breast cancer mortality in relation to self-reported use of breast self-examination. A cohort study of 450 000 women. Breast Cancer Res. Treat., 43, 1997, s. 137-40.
  20. Knudson, A.G., Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci., 68, 1971, s. 820 - 23.
  21. Lane D.P.: P53, quardian of the genome. Nature. 358, 1992 s. 15-16.
  22. Miller, A.B., Baines, C.J., To, T., Wall, C.: Canadian National Breast Screening Study 2: Breast cancer detection and death rates among women aged 50 to 59 years, Can Med. Assoc. J.: 147, 1992, s. 1477-1485.
  23. Miller, A.B., To, T., Baines, C.J., Wall, C.: The Canadian National Breast Screening Study: update on breast cancer mortality, Monogr. Natl. Cancer Inst., 22, 1997, s. 37-44.
  24. Morrison A.S.: Is self-examination effective in screening for breast cancer. J. Natl. Cancer Inst., 83, 1991, s. 226-27.
  25. Narod, S.A.: Familial breast-ovarian cancer locus on chromosome 17q-12q23. Lancet, 338, 1991, s.82-83
  26. Narod, S.A.: Hereditary breast carcinoma syndromes. Cancer. 80, 1997, 3, (Suppl), s. 537-42.
  27. Olsen, O., Gotzsche, P.C.: Systematic review of screening for breast cancer with mammography, Lancet, 358, 2001, 9290.
  28. Pontén, J., Holmberg, L., Trichopoulos, D., Kallioniemi, O,P., Kvale, G., Wallgren, A., Papadimitriou, J.T.: Biology and natural history of breast cancer. Int. J. Cancer, (Suppl 5), 1990, s. 5 - 21.
  29. Rhei, E., Kang L., Bogomolniy, F., Federici, M.G., Borgen, P.I., Boyd, J.: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC 1 in primary breast carcinomas. Cancer Res., 57, 1997, 17, s. 3657-59.
  30. Shapiro, S., Venet, W., Strax, P., Venet, L.: Periodic screening for breast cancer: the health insurance plan project and its sequelae, Baltimore, John Hopkins Press, 1988
  31. Swift, M., Reitnauer, P.J., Morrell, D., Chase, C.L.: Breast and other cancers in families with ataxia-telangiectasia. NEJM, 316, 1987, s. 1289 - 94.
  32. Tabar, L., Fagerberg, G., Chen, H.H., Duffy, S.W., Smart, C.R., Gad, A.: Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial, Cancer, 75, 1995, s. 2507-2512.
  33. UZIS ČR 200, Novotvary 1997.
  34. Varey, J.M., Evans D.G.R.: Li-Fraumeni syndrome-a molecular and clinical review. Br. J. Cancer, 76, 1997, 1, s. 1-14.
Copyright © 2002-2017 Senologická sekce ČGPS
Vyrobila firma Medimarket s.r.o. v rámci projektu MEDIMA.cz
Reklama MEDIMA.cz